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Abstract Cyanate is formed mostly during nonenzymatic
urea biodegradation. Its active form isocyanate reacts with
protein –NH2 and –SH groups, which changes their struc-
ture and function. The present studies aimed to investigate
the effect of cyanate on activity of the enzymes, which
possess –SH groups in the active centers and are implicated
in anaerobic cysteine transformation and cyanide detoxifi-
cation, as well as on glutathione level and peroxidative
processes in different brain structures of the rat: cortex,
striatum, hippocampus, and substantia nigra. In addition, we
examined whether a concomitant treatment with lipoate, a
dithiol that may act as a target of S-carbamoylation, can
prevent these changes. Cyanate-inhibited sulfurtransferase
activities and lowered sulfide level, which was accompa-
nied by a decrease in glutathione concentration and eleva-
tion of reactive oxygen species level in almost all rat brain
structures. Lipoate administered in combination with cya-
nate was able to prevent the above-mentioned negative
cyanate-induced changes in a majority of the examined
brain structures. These observations can be promising for
chronic renal failure patients since lipoate can play a double
role in these patients contributing to efficient antioxidant
defense and protection against cyanate and cyanide toxicity.
Keywords Cyanate  Lipoate  Sulfane sulfur  Hydrogen
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Introduction
In biological systems, cyanate shows the highest reactivity
with sulfhydryl (SH) groups of proteins (Arlandson et al.
2001; Wisnewski et al. 1999). Since –SH groups are
present in active centers of enzymes participating in
anaerobic cysteine transformation, e.g., cystathionase
(CSE, EC 4.2.1.15) and mercaptopyruvate sulfurtransferase
(MPST, EC 2.8.1.2), and sulfane sulfur transporting
enzyme, e.g., rhodanese–thiosulfate sulfurtransferase (TST,
EC 2.8.1.1) (Nagahara et al. 1995, 2003), it was hypothe-
sized that cyanate could influence the activity of these
enzymes as well as the level of the main cellular antioxi-
dant, glutathione (GSH).
Cysteine, which is formed from exogenous methionine, is
both the GSH precursor and the main source of active sulfur
in tissues. Sulfur-containing compounds can possess a stably
bound sulfur, as that in glutathione and cysteine or labile
sulfur, e.g., acid labile, sulfane sulfur (S*), and protein bound
sulfane sulfur. S* is a highly reactive sulfur in 0 or -1 oxi-
dation state covalently bound to another sulfur atom. The
pool of sulfane sulfur-containing compounds comprises,
e.g., polysulfides (R–S–Sn*–S–R), thiosulfate (S2O3
2-), and
persulfides (R–S–S*H), which are formed during biodegra-
dation of cystine and mixed disulfides (Fig. 1) in the pres-
ence of CSE and cystathionine b-synthase (CBS, EC
4.2.1.22). S* plays an important role in cyanide (CN-) to
thiocyanate (SCN-) detoxification catalyzed by TST,
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MPST, and by CSE (Nagahara et al. 1995, 1999, 2003;
Toohey 1989). Most of the labile sulfur is liberated as inor-
ganic sulfides, e.g., H2S, HS
-, or S2-, in the presence of acids
or reducing agents (Toohey 1989, 2011; Ubuka 2002). On
the other hand, hydrogen sulfide can be stored in the form of
protein bound sulfane sulfur (Shibuya et al. 2009). It indi-
cates a close relation between H2S and sulfane sulfur. In the
brain, hydrogen sulfide (H2S) fulfills the function of neuro-
transmitter and vasodilator. It was believed earlier that the
formation of the main pool of hydrogen sulfide in the brain
was catalyzed by CBS, while in the periphery by cystathio-
nine c-lyase—CSE (Chen et al. 2004; Li et al. 2006; Stipanuk
2004; Toohey 2011). However, the most recent studies have
demonstrated that hydrogen sulfide synthesis in the brain
tissue is catalyzed mostly by MPST (in the presence of thi-
oredoxin or dihydrolipoic acid) (Shibuya et al. 2009; Mikami
et al. 2011) (Fig. 1).
Our earlier studies demonstrated prooxidative properties
of cyanate and its inhibitory action on enzymatic activities
of sulfurtransferases while lipoic acid [IUPAC name:
5-(1,2-dithiolane-3-yl)pentanoic acid] (Fig. 2) prevented
that effect in the rat liver (Sokolowska et al. 2011). Hence,
we expected to see similar effect in the rat brain. However,
the effect of cyanate on antioxidant enzyme activity and
H2S level was unknown. Since oxidative stress can dif-
ferently affect antioxidant enzyme activity in various brain
regions (Severynovs’ka et al. 2006; Mladenović et al.
Fig. 1 Sulfane sulfur (S*) formation by biodegradation of L-cystine
to L-thiocysteine, catalyzed by CSE (3) and of homocysteine and
cysteine mixed disulfides to L-thiohomocysteine, catalyzed by CBS
(4). The main pathways of hydrogen sulfide (H2S) formation: by
desulfurization of 3-mercaptopyruvic acid catalyzed by MPST (2);
during cystathionine synthesis catalyzed by CBS (4); in b- and a,b-
elimination reactions of L-cysteine, catalyzed by CSE (3) and CBS
(4); in the reaction of persulfides (e.g., thiocysteine, thiohomocys-
teine) with an excess of cellular reducers (RSH)
Fig. 2 The structure of oxidized (LA) and reduced (DHLA) form of
lipoic acid
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2012), we expected to observe diverse effects of cyanate in
different brain structures. The effect of cyanate on the
organism can be particularly significant in uremia in which
plasma level of urea (a cyanate (OCN-) and isocyanate
(NCO-) precursor (Fig. 3) is significantly increased
(Beddie et al. 2005; Estiu and Merz 2007; Vanholder et al.
2003). This compound can also affect brain tissue because
both, in vitro and in vivo studies with 14C radiolabeled
cyanate documented its incorporation into cerebral proteins
in the process of S- and N-carbamoylation (Crist et al.
1973; Fando and Grisolia 1974).
Lipoic acid (LA) (Fig. 2), due to its structure, may act as
a target of carbamoylation and in this way may protect –SH
groups of proteins. In addition, LA is a very strong anti-
oxidant able to quench free radicals and restore the activity
of other antioxidants. Since LA participates also in the
regulation of sulfane sulfur metabolism, it is probable that
it can show a protective action against harmful effects of
cyanate in brain structures (Bilska et al. 2008; Smith et al.
2004). These data prompted us to investigate the effect of
cyanate and lipoate alone and in combination on anaerobic
cysteine transformation, in particular on hydrogen sulfide
level and activity of sulfane sulfur synthetic and transport
enzymes, and on the concentrations of pro- and antioxi-
dants in different structures of the brain: cortex, striatum,
hippocampus, and substantia nigra (SN).
Materials and Methods
Animals
The experiments were carried out on male Wistar rats
weighing *250 g. The animals were kept under standard
laboratory conditions and were fed a standard diet. All
experiments were carried out in accordance with the
National Institutes of Health Guide for the Care and Use of
Laboratory Animals and with approval of the Bioethics
Commission as compliant with the Polish Law (21 August
1997) (permission no. 645, 23.04. 2009). Animals were
assigned to four groups, containing 7 animals each. Groups
were treated as follows.
Group 1
Group 2
Group 3
0.9% NaCl O.9% NaCl 0.9% NaCl sacrifice
0 30 60 150 min
0.9% NaCl cyanate 0.9% NaCl sacrifice
0 30 60 150 min
lipoate 0.9% NaCl lipoate sacrifice
0 30 60 150 min
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Cyanate (KCNO) was administered intraperitoneally
(i.p.) at a dose of 200 mg/kg b.w. The dose of cyanate was
chosen based on the data presented in the article by Tor-
Agbidye et al. (1999). The dose of lipoic acid (LA) 50 mg/kg
b.w. i.p. twice was chosen on the basis of our earlier studies
(Bilska et al. 2008). Efficacy of this dose was confirmed by
literature data (Micili et al. 2013; Shay et al. 2009).
Animals were sacrificed 2.5 h after the first injection,
because there had to be an interval between preventive lipoate
administration and cyanate dose, and then the next therapeutic
LA treatment (aimed to lower cyanate action). Subsequently,
the above-mentioned brain structures were isolated and stored
at -80 C until further experiments were performed.
Biological Material
The tissues were weighed and homogenized in 400 ll of an
ice-cold phosphate buffer, pH 7.4 per 100 mg of the tissue.
Substantia nigra specimens (left and right ca. 5–8 mg)
originating from three rats were pooled and homogenized
in the same manner (on the average 80 ll of an ice-cold
phosphate buffer, pH 7.4 per 20 mg of the tissue).
Chemicals
Potassium cyanide (KCN), dithiothreitol, p-phenylenedi-
amine, N-ethylmaleimide (NEM), b-nicotinamide adenine
dinucleotide reduced form (NADH), 5,50-dithio-bis-2-
nitrobenzoic acid (DTNB), NADPH, mercaptopyruvic acid
sodium salt L-homoserine, pyridoxal 50-phosphate mono-
hydrate, 3-methyl-2-benzothiazolinone hydrazone hydro-
chloride monohydrate, and lactic dehydrogenase (LDH),
potassium cyanate (KNCO), glutathione reduced form,
glutathione reductase, and a-lipoic acid sodium salt were
provided by Sigma Chemical Co. (St. Louis, MO, USA).
Formaldehyde, ferric chloride (FeCl3), thiosulfate, and all
the other reagents were obtained from the Polish Chemical
Reagent Company (P.O.Ch, Gliwice, Poland).
Methods
1. Glutathione (GSH) level was determined by the
method of Ellman (1959).
2. c-Glutamyltransferase (cGT) activity was assayed by
the method of Orłowski and Meister (1963).
3. Activity of glutathione peroxidase (GPx) was assayed
by the method of Flohe and Gunzler (1984).
4. Catalase activity was determined according to Aebi
(1984).
5. Activity of rhodanese (TST) was determined using the
method of Sörbo (1955).
6. MPST activity was assayed according to Valentine and
Frankelfeld (1974).
7. CSE activity was determined by the method of Matsuo
and Greenberg (1958).
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8. Sulfane sulfur (S*) level was assayed by a cold
cyanolysis method (Wood 1987).
9. Hydrogen sulfide/sulfides level was determined using a
modification of the method of Tamizhselvi et al.
(2007).
Briefly, the assay was based on the fact that H2S pro-
duced in the brain tissues reacts with Zn(CH3COO)2 to
form ZnS which than reacts with p-phenylenediamine
yielding a fluorescent dye (thionein) in the presence of
ferric chloride (FeCl3). Aliquots of homogenate (125 ll)
were mixed with 1 mM Na2CO3 (125 ll) and 5 % zinc
acetate (125 ll) followed by incubation at room tempera-
ture (30 min). Next, p-phenylenediamine (12.5 mM),
40 mM FeCl3 in 6 M HCl, and H2O (125 ll) were added.
After a 10-min development at room temperature, the
samples were centrifuged for 5 min in 10,0009g and
fluorescence of the mixture was measured (Ex 600 nm, Em
623 nm). H2S concentrations were read from a calibration
curve prepared from thionein (2.5–25 lM).
10. Reactive oxygen species (ROS) level was assayed by
the method of Bondy and Guo (1994).
11. Protein content was determined according to Lowry
et al. (1951).
Statistical Analysis
The results are presented as the mean ± SEM for each
group. Statistically significant differences between groups
were calculated using a two-way ANOVA, followed (if
significant) by the Tukey test for comparison between the
examined groups.
Results
GSH Concentration
Cyanate significantly lowered GSH concentration in all
structures of the rat brain under study (Fig. 4).
The most pronounced decrease in GSH content after
cyanate injection was observed in the cortex and in the
striatum (by 33 and 35 % vs. control, respectively), mod-
erate in the hippocampus (by 27 % of the control), and the
smallest one in the substantia nigra (by 20 %). Lipoate
alone treatment significantly elevated GSH level only in
the hippocampus (by 32 % of the control group). Lipoate
administrated jointly with cyanate (before and after cya-
nate) enhanced GSH concentration the most distinctly in
the cortex and striatum (by 30 and 52 % of the control
level, as well as by 93 and 134 % of the cyanate-treated
group, respectively) but slightly weaker in the hippocam-
pus and substantia nigra (SN) (by 18 and 6 % vs. control
group, and by 45 and 47 % of the cyanate-treated group,
respectively) (Fig. 4).
cGT Activity
Cyanate administration significantly reduced c-glutamyl-
transferase (cGT) activity, but only in the cortex (by 50 %
of the control group). Lipoate treatment decreased activity
of the enzyme versus control (by 32 %), but joint treatment
with cyanate and lipoate partially restored activity of the
enzyme in this structure (by 66 % of cyanate-treated
group), however, it did not reach activity of this enzyme in
the control (Fig. 5).
Fig. 4 The effect of acute
administration of cyanate (CY,
200 mg/kg) and lipoate (L,
50 mg/kg twice), alone and in
combination (LCY) on the total
GSH level. Data are presented
as the mean ± SEM, n = 21 for
each group of cortex samples,
n = 10 for hippocampus
samples, n = 9 for each group
of striatum samples, and n = 5
for substantia nigra samples.
Symbols indicate significance of
differences in the Tukey test,
***P \ 0.001, **P \ 0.01,
*P \ 0.05 versus control (C);
###P \ 0.001 versus CY group;
DDDP \ 0.001, DDP \ 0.01
versus L-treated group
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GPx and Catalase Activities
Cyanate significantly lowered GPx activity in the cortex (by
70 % of the control) and catalase activity both in the cortex
and striatum (by 43 and 20 % of the control, respectively)
(Fig. 6). Lipoate alone maintained GPx activity at the
control level, while administrated in combination with
cyanate restored activity of this enzyme versus control
group and simultaneously raised it by 250 % versus the
cyanate group. Lipoate alone maintained catalase activity in
the cortex at the control level, while in the striatum
increased it markedly in comparison to the control group
(by 50 %). Lipoate administrated jointly with cyanate not
only restored the catalase activity in the cortex and striatum,
but even enhanced it markedly in the striatum (by 93 % of
the control). Consequently in the cortex and striatum, cat-
alase activity was significantly higher (by 102 and 142 %,
respectively) than in the cyanate group (Fig. 6).
TST and MPST Activity
Administration of cyanate markedly reduced TST activity
in the substantia nigra (SN) (by 32 % of the control) and in
the cortex (by 31 %), but slightly more weakly in the
striatum (by 20 %). MPST activity in the SN (by 25 % of
the control) and striatum (by 21 %) also declined. Cyanate
did not change activities of both enzymes in the hippo-
campus. Lipoate alone enhanced significantly activities of
these enzymes in the hippocampus; TST by 32 % of the
control and by 66 % of the cyanate-treated group, while
MPST by 38 % of the control and by 58 % of the cyanate-
treated group, and TST activity in the SN (by 6 % of the
control and 57 % of the cyanate-treated group). Lipoate
administrated jointly with cyanate significantly raised TST
activity versus control only in the hippocampus (by 30 %);
while in the cortex (by 47 %), SN (44 %) and in the stri-
atum (by 17 %) when compared to the cyanate-treated
group.
As to MPST, apart from the hippocampus, lipoate alone
enhanced activity of the enzyme in the cortex (by 25 % of
the control and by 56 % of the cyanate-treated group),
while decreased it in the striatum (by 26 % of the control).
After the combined treatment with cyanate and lipoate,
MPST activity was increased in the striatum (by 17 %,
when compared to the control and by 47 % vs. the cyanate-
treated group), in the cortex and in the SN (by 38 % and by
10 % of the cyanate-treated group, respectively). Lipoate
in combination with cyanate did not changed MPST
activity in the hippocampus (Fig. 7).
Cystathionase (CSE) Activity
CSE activity was the highest in the hippocampus. Cyanate
significantly lowered CSE activity both in the cortex and
striatum (by 52 % of the control). Lipoate alone enhanced
activity of the enzyme versus control only in the hippo-
campus (by 44 %). Lipoate administrated jointly with
cyanate (before and after cyanate) elevated its activity
versus cyanate group, in all structures under study, i.e., in
the cortex (by 98 % of the cyanate-treated group), in the
striatum (by 39 %), and hippocampus (by 65 % of the
value after cyanate treatment) (Fig. 8).
Sulfide and Sulfane Sulfur Level
Cyanate significantly lowered the level of sulfides/H2S in
the cortex (by 41 % of the control) and striatum (by 30 %
Fig. 5 The effect of acute administration of cyanate (CY, 200 mg/
kg) and lipoate (L, 50 mg/kg twice), alone and in combination (LCY)
on the enzymatic activity of c-glutamyl transferase (c-GT) expressed
in U/mg (lmol of p-nitroaniline formed during 1 min/mg protein).
Data are presented as the mean ± SEM, n = 18 for each group of
cortex samples, n = 12 for hippocampus samples, and n = 9 for each
group of striatum samples. Symbols indicate significance of differ-
ences in the Tukey test, **P \ 0.001 versus C; ###P \ 0.001,
##P \ 0.01 versus CY; DP \ 0.05 versus L-treated group
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of the control), and sulfane sulfur (S*) level in the cortex
(the only structure in which S* was determined because of
the lack of material from other structures) (by 24 % of the
control). Lipoate alone decreased the concentration of
sulfides in the striatum, by 21 % and in the hippocampus,
by 30 % of the control. In the cortex, lipoate administrated
alone elevated neither the level of S* nor sulfides versus
control, but combined treatment with cyanate and lipoate
raised the level of sulfides in the cortex (by 67 % of cya-
nate-treated group) and restored the concentration of sul-
fides to the control level (Fig. 9).
ROS Level
After cyanate treatment, the level of free radicals increased
in all structures under study: in the cortex by 71 %, in the
hippocampus by 58 %, and in the striatum by 30 % of the
control group. Lipoate alone significantly decreased the
concentration of ROS only in the striatum (by 55 % vs.
control). Administration of cyanate and lipoate signifi-
cantly lowered ROS level in all the structures: in the cortex
by 28 % of the cyanate-treated group, in the striatum by
41 % while in the hippocampus by 42 % of the cyanate-
treated group, i.e., it restored ROS level in the cortex and
hippocampus almost to the control level, while in the
striatum even decreased it below this level. (Fig. 10).
Discussion
Reduction of glutathione (GSH) level as well as sulfur-
transferase (TST, CSE) and catalase activities (Figs. 4, 6,
7, 8) accompanied by an increase in free radical level
(Fig. 10) was observed in almost all rat brain structures
after cyanate treatment, through to different degree. It may
indicate prooxidative action of cyanate and following
Fig. 6 The effect of acute
administration of cyanate (CY,
200 mg/kg.) and lipoate (L,
50 mg/kg twice), alone and in
combination (LCY) on the
enzymatic activities of catalase
(a–c) and glutathione
peroxidase (GPx; d, e). Activity
of catalase was expressed in
U/mg (lmol of H2O2 degraded
by the enzyme/mg of protein/
min), while activity of
glutathione peroxidase was
expressed in mU/mg (nmol of
GSH, oxidized by the enzyme
during 1 min/mg protein). Data
are presented as the
mean ± SEM, n = 21 for each
group of cortex samples, n = 10
for hippocampus samples, and
n = 9 for each group of
striatum samples. Symbols
indicate significance of
differences in the Tukey test,
***P \ 0.001, **P \ 0.05
versus control (C); ###P \ 0.001
versus CY; DDDP \ 0.001
versus L-treated group
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carbamoylation of proteins, especially –SH groups of sul-
furtransferases and GSH. Cyanate-induced lowering of
GSH level of varying magnitude was also reported by Tor-
Agbidye et al. (1999) in different mouse brain structures.
On the other hand, carbamoylation is corroborated by
reports demonstrating cyanate incorporation into cerebral
proteins and a direct cyanate reaction with GSH (Crist et al.
1973; Fando and Grisolia 1974; Stark et al. 1960;
Fig. 7 The effect of acute
administration of cyanate (CY,
200 mg/kg) and lipoate (L,
50 m/kg twice), alone and in
combination (LCY) on
enzymatic activities of
thiosulfate (TST) and
mercaptopyruvate (MPST)
sulfurtransferases (a–d) in the
rat brain structures. TST and
MPST activities were expressed
in U/mg (lmoles of SCN-/mg
of protein/min; lmoles of
pyruvate/mg of protein/min,
respectively). Data of TST and
MPST activities are presented
as the mean ± SEM, n = 18,
n = 12, n = 9, and n = 6 for
each group of cortex,
hippocampus, striatum, and
substantia nigra samples,
respectively. Symbols indicate
significance of differences in the
Tukey test, ***P \ 0.001,
**P \ 0.01, *P \ 0.05 versus
control (C); ###P \ 0.001,
##P \ 0.01, #P \ 0.05 versus
CY; DDDP \ 0.001 versus
L-treated group
352 Neurotox Res (2013) 24:345–357
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Wisnewski et al. 1999). The decrease in GSH level, the
most notable in the cortex and in the striatum, can also be
the result of CSE inhibition in these structures since this
enzyme supplies cysteine, a rate-limiting substrate for
glutathione synthesis. GSH (c-glutamylcysteinyl glycine)
biosynthesis in brain cells is catalyzed by c-glutamylcys-
teine ligase (GCL), which is a rate-limiting enzyme, and
glutathione synthetase (GS). On the other hand, GSH is
catabolized to glutamate, cysteine, and glycine which can
be reused for GSH synthesis catalyzed by the transmem-
brane enzyme cGT. Therefore, the decrease in cGT activity
observed in the cortex can contribute to the drop in GSH
level in this structure. Since GSH is the main cellular
antioxidant which participates in reactive oxygen species
(ROS) scavenging and removal of hydrogen peroxide and
organic peroxides, a decrease in its level elevates ROS
level. The cyanate-induced increase in ROS level could
also be attributed to the decreased level of hydrogen sulfide
in the cortex and in the striatum, because H2S inhibits ROS
formation under natural conditions by inhibiting NADH
oxidase activity (Samhan-Arias et al. 2009). Since physi-
ological concentration of H2S also increases the activity of
the cystine–glutamate antiporter (Xc-) and of c-glutam-
ylcysteine synthase, the drop in H2S concentration in the
cortex and in the striatum (Fig. 9) can indirectly affect
GSH level (Kimura and Kimura 2004; Kimura et al. 2010).
According to Chen et al. (2004), CBS is the only enzyme
able to produce H2S in the brain. However, biochemical
studies of Linden et al. (2008) evidenced CSE expression
and H2S production in the mouse brain. CSE activity was
also present in various regions of the rat brain from a
6-month-old infant at autopsy (Stipanuk 2004). In the
hippocampus neither MPST (the main H2S-producing
enzyme) nor CSE activity was changed by cyanate, which
was manifested as an unaltered sulfide/H2S level (Figs. 7,
8, 9). The cyanate-induced lowering of H2S level in the
cortex and striatum correlates with the decrease in CSE
activity in both structures and MPST activity in the stria-
tum. The inhibitory effect of cyanate on CSE activity also
leads to depletion of the so-called sulfane sulfur pool in the
cortex. In addition, the decline in TST and MPST activities
(which under physiological conditions are about 5–10
times lower in the brain than in other organs, like the
kidney or heart) can increase sensitivity of the brain
structures (especially striatum and SN) to the CN- toxicity,
leading to the inhibition of cytochrome oxidase, and thus to
the decrease in ATP level and neuropathy (de Sousa et al.
2007; Hasuike et al. 2004; Nagahara et al. 1999).
H2S was shown to increase the activity of neuronal
N-methyl-D-aspartate (NMDA) receptor, activating calcium
channels and leading to a prolonged enhancement of long-
term potentiation (LPT) which is of key significance for some
forms of learning and memory (Nagai et al. 2004; Kimura and
Kimura 2004). No changes in the hippocampal MPST activity
and H2S level after acute cyanate treatment can indicate
undisturbed perceptive processes in rats under these condi-
tions. On the other hand, hippocampal hydrogen sulfide level,
unaffected by cyanate, suggests an undisturbed functioning of
the Xc- antiporter to supply cystine, and unhindered GSH
synthesis in this structure of the brain (Kimura et al. 2010). In
that case, the decrease in GSH level, slightly smaller than in
other structures (Fig. 9), could be an immediate consequence
of its direct carbamoylation by cyanate.
Although the mechanism of catalase (in the cortex and
striatum) and GPx (in the cortex) inhibition is not known in
Fig. 8 The effect of acute administration of cyanate (CY, 200 mg/kg)
and lipoate (L, 50 mg/kg twice), alone and in combination (LCY) on
the enzymatic activity of c-cystathionase (CSE; a–c). CSE activity was
expressed in U/mg (lmoles of a-ketobutyric acid formed from
homoserine/mg of protein/min). Data are presented as the mean ±
SEM, n = 18 for each group of cortex samples, n = 9 for hippocam-
pus and striatum samples. Symbols indicate significance of differences
in LSD test, ***P \ 0.001, **P \ 0.01, *P \ 0.05 versus control (C);
###P \ 0.001) versus CY; DDDP \ 0.001 versus L-treated group
Neurotox Res (2013) 24:345–357 353
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detail, there are reports demonstrating a decrease in
activities of these enzymes in the rat brain during oxidative
stress (Hfaiedh et al. 2012; Bild et al. 2012), and various
stress effects on antioxidant enzymes in different brain
structures (Mladenovic et al. 2012). However, it would be
difficult to compare those results with the present data due
to completely different stress conditions.
The increase in GSH level after the combined admin-
istration of cyanate and lipoate was the greatest in those
structures where it was decreased the most by cyanate, i.e.,
in the cortex and in the striatum, which can indicate a
stimulating lipoate effect during cyanate-induced oxidative
stress. Both LA and its reduced form DHLA easily cross
the blood–brain barrier thus creating redox system with a
low redox potential (Eo = -0.29 V), capable of regenera-
tion of other cellular antioxidants, including GSH and
cysteine (CSH) (by the reduction of respective disulfides:
GSSG and CSSC) (Biewenga et al. 1997; Shay et al. 2009).
It was confirmed by literature reports indicating the
increase in GSH concentration in cell cultures and animal
tissues after lipoate administration (Busse et al. 1992; Shay
et al. 2009; Wessner et al. 2006). CSE activation after
lipoate ? cyanate administration, observed in the cortex,
striatum, and to the greatest degree in the hippocampus,
could lead to elevation of the concentration of cysteine, a
GSH precursor (Fig. 1). According to Smith et al. (2004),
there are two paths by which LA/DHLA can increase GSH
level: (1) boosting of cysteine availability by extracellular
cystine reduction and (2) facilitation of cystine uptake by
enhancement of Xc- transport system (cystine/glutamate
antiporter) expression. The recent hypothesis suggests that
LA increases total antioxidant capacity of cells by induc-
tion of antioxidant response element (ARE)-regulated gene
transcription, including those encoding c-glutamylcysteine
ligase, an enzyme participating in the first stage of GSH
synthesis. ARE region can also partially regulate of Xc-
system contributing to transport of cystine, which is the
main substrate for GSH production (Shay et al. 2009).
Lipoate was also able to restore sulfutransferase activi-
ties (Figs. 7, 8) in all structures under study (except for
MPST activity in the hippocampus which was not changed
by cyanate). Lipoate’s ability to restitute activity of rho-
danese (and probably other sulfurtransferases possessing
S* binding domain, e.g., MPST and CSE) (Toohey 2011)
can be attributed to the fact that the reduced form of lipoate
can be an acceptor of sulfane sulfur from the rhodanese
active center (Villarejo and Westley 1963) (Fig. 11). It is
accompanied by H2S formation, confirmed by its increased
cortical level after lipoate administration (Fig. 9), which
could lead to c-glutamylcysteine synthetase and cystine
transporter (Xc-) activation and acceleration of GSH
synthesis (Kimura and Kimura 2004). Since hydrogen
sulfide more increases cysteine than cystine transport, and
parallely cysteine uptake by ASC transporter is faster than
cystine uptake by Xc- system, it appears that ASC-
involving mechanism can be decisive for elevation of GSH
Fig. 9 The effect of acute administration of cyanate (CY, 200 mg/kg.)
and lipoate (L, 50 mg/kg twice), alone and in combination (LCY) on
the level of sulfides (a, c, d) and sulfane sulfur (S*) (b). Concentration
of sulfides was expressed in nmoles of thionine/mg of protein and of
sulfane sulfur in nmoles of SCN-/mg. Data are presented as the
mean ± SEM, n = 18 for each group of cortex samples, n = 12 for
hippocampus and n = 9 for each group of striatum samples. Symbols
indicate significance of differences in the Tukey test, ***P \ 0.001,
**P \ 0.01, *P \ 0.05 versus control (C); ###P \ 0.001, #P \ 0.05
versus CY; DP \ 0.001 versus L-treated group
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synthesis by H2S (Kimura et al. 2010; Smith et al. 2004).
To sum up three factors could contribute to the reduction of
ROS level after the combined administration of cyanate
and lipoate: (1) the increase in GSH level (in all studied
structures), (2) the increase in the activity of antioxidant
enzymes: catalase (in the cortex and striatum) and GPx (in
the cortex), and (3) the increase in H2S concentration (in
the cortex), which inhibits ROS formation (Samhan-Arias
et al. 2009). All these factors may be decisive for antiox-
idant protection of neurons in the cortex and striatum.
Additional protection can be obtained due to LA-induced
reestablishment of the activities of sulfurtransferases,
involved in the production of strongly antioxidant sulfane
sulfur. Thus, lipoate administered in combination with
cyanate was able to restore cyanide detoxifying capabilities
to brain cells. The protective effect of LA administrated in
a rat sciatic nerve injury model is another confirmation of
restorative lipoate action on the nervous tissue (Ranieri
et al. 2010). The increased level of oxidized and carba-
moylated low density lipoproteins (LDL) and proteins,
detected in atherosclerotic plaques and cholesterol depos-
its, can suggest a role of both cyanate and oxidative stress
in pathogenesis of atherosclerosis and cerebral stroke (Asci
et al. 2008; Shah et al. 2008; Wang et al. 2007). Since LA
decreased ROS level (Fig. 10) and concomitantly might act
as a target for carbamoylation, thus lowering cLDL level, it
is able both to alleviate the symptoms of neuropathy
observed in CRF patients and to decrease the risk of
cerebral stroke. Although cyanate toxicity after acute
treatment is relatively low, long-term effects of its action
can be much more serious (Alter et al. 1974).
Conclusions
This article presents the studies demonstrating that the
treatment of rats with cyanate alone lowered GSH level and
raised reactive oxygen species (ROS) level in all structures
of the brain. Besides, cyanate was shown to inhibit TST
and CSE activities, to decrease sulfide/hydrogen sulfide
level in all structures except for the hippocampus, and to
inhibit the activities of MPST (in the striatum and sub-
stantia nigra), catalase (in the striatum and cortex), and
peroxidase (in the cortex). This indicates that cyanate
inhibits anaerobic cysteine transformation and shows pro-
oxidant action in almost all structures of the brain. From
among the above-mentioned changes, lipoate administered
in combination with cyanate was able to correct ROS and
Fig. 10 The effect of acute administration of cyanate (CY, 200 mg/kg.)
and lipoate (L, 50 mg/kg twice), alone and in combination (LCY) on
the level of reactive oxygen species (ROS; a–c). Concentration of
ROS was expressed in nmoles of 2,7-dichlorofluorescein (DCF)/mg
of protein. Data are presented as the mean ± SEM, n = 18 for each
group of cortex samples, n = 11 for hippocampus, and n = 9 for
striatum samples. Symbols indicate significance of differences in the
Tukey test, ***P \ 0.001, **P \ 0.01 versus control (C);
###P \ 0.001, ##P \ 0.01 versus CY; #P \ 0.05 versus CY;
DDP \ 0.001 versus L-treated group
Fig. 11 Reactivation of rhodanese in the reaction with DHLA,
leading to H2S production. The persulfide form of rhodanese
(rhodanese–S–S*H) is inactive contrary to the hydrosulfide form
(rhodanese–S–H)
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GSH levels, as well as activities of sulfurtransferases,
catalase, and peroxidase. It indicates that lipoate can pre-
vent prooxidant cyanate action and cyanate-induced inhi-
bition of enzymes engaged in anaerobic cysteine
transformation and cyanide detoxication as well as can
activate antioxidant enzymes. These observations can be
promising for prophylaxis and alleviation of symptoms of
cerebral stroke and neurodegenerative diseases especially
in chronic renal failure patients since lipoate can play a
dual role in these patients contributing to efficient antiox-
idant defense and protection against cyanate and cyanide
toxicity.
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